Truist Financial Corp cut its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 9.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,238 shares of the real estate investment trust’s stock after selling 2,315 shares during the quarter. Truist Financial Corp’s holdings in Omega Healthcare Investors were worth $762,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the business. Cutter & CO Brokerage Inc. increased its holdings in Omega Healthcare Investors by 3.7% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock worth $281,000 after acquiring an additional 290 shares during the last quarter. Pasadena Private Wealth LLC grew its position in shares of Omega Healthcare Investors by 2.9% during the 2nd quarter. Pasadena Private Wealth LLC now owns 12,049 shares of the real estate investment trust’s stock valued at $413,000 after purchasing an additional 335 shares in the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors raised its holdings in shares of Omega Healthcare Investors by 4.7% in the 2nd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 7,574 shares of the real estate investment trust’s stock valued at $259,000 after acquiring an additional 342 shares in the last quarter. Tidal Investments LLC boosted its position in shares of Omega Healthcare Investors by 2.5% during the 1st quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock valued at $454,000 after acquiring an additional 348 shares during the last quarter. Finally, Future Financial Wealth Managment LLC grew its holdings in shares of Omega Healthcare Investors by 5.0% during the first quarter. Future Financial Wealth Managment LLC now owns 8,403 shares of the real estate investment trust’s stock worth $266,000 after purchasing an additional 400 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of research firms have recently issued reports on OHI. BMO Capital Markets lifted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Scotiabank boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their target price for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Truist Financial boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus price target of $37.00.
Insider Activity at Omega Healthcare Investors
In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.
Omega Healthcare Investors Stock Performance
Omega Healthcare Investors stock opened at $39.96 on Tuesday. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $41.53. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $9.87 billion, a P/E ratio of 36.00, a PEG ratio of 1.28 and a beta of 1.00. The stock’s 50 day moving average is $39.43 and its 200 day moving average is $35.02.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The company had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. During the same quarter in the previous year, the business earned $0.74 earnings per share. Omega Healthcare Investors’s revenue was up 17.5% compared to the same quarter last year. On average, equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.
Omega Healthcare Investors Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were issued a $0.67 dividend. The ex-dividend date was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a yield of 6.71%. Omega Healthcare Investors’s payout ratio is currently 241.44%.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Further Reading
- Five stocks we like better than Omega Healthcare Investors
- How Can Investors Benefit From After-Hours Trading
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- 5 Top Rated Dividend Stocks to Consider
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.